Welt report uncovers evidence of serious irregularities in the Pfizer phase 3 Comirnaty trial: Attempts to cover up adverse events
eugyppius | Welt report uncovers evidence of serious irregularities in the Pfizer phase 3 Comirnaty trial, suggesting systematic attempts to cover up adverse events at the Argentine clinical site. | Pfizer enrolled 44,000 people across 270 clinical sites in the phase 3 clinical trials for the Pfizer/BioNTech Comirnaty vaccine. The largest of these sites by far was number 1231 in Buenos Aires, under the direction of the pediatric infectious diseases specialist Fernando Polack. The Argentine operation appears to have been plagued by substantial irregularities and is the subject of an ongoing inquiry by the Argentine parliament. ● Yesterday, Welt reporter Elke Bodderas published a report shedding further light on what appear to be systematic efforts to cover up or reclassify adverse events among trial participants.